Free Trial Information
BioCentury | Oct 8, 2019
Emerging Company Profile

Flagship unveils Cygnal, a nervy take on cancer, inflammation

...seven bioelectronics companies via its $50 million Action Potential Venture Capital fund. Among these is SetPoint Medical Inc....
Read More
BioCentury | Jun 21, 2017
Company News

Management tracks

...Öhd to CMO, a newly created position, from director of clinical R&D. Inflammatory disease company SetPoint Medical Inc....
Read More
BioCentury | Aug 8, 2016
Product Development

Galvanizing bioelectronics

...a winner." Meanwhile, GSK's Action Potential Venture Capital fund has funded five bioelectronics companies, including SetPoint Medical Inc....
...NYSE:GSK), London, U.K. NeuSpera Medical Inc., San Jose, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland SetPoint Medical Inc....
Read More
BioCentury | Jan 5, 2015
Clinical News

Cyberonics Vagus Nerve Stimulation System: Clinical trial started

...an open-label, European trial to evaluate Cyberonics Vagus Nerve Stimulation System in about 15 patients. SetPoint Medical Inc....
Read More
BioCentury | Aug 19, 2013
Finance

Electric with potential

...made its maiden investment this month by participating in a $27 million private round in SetPoint Medical Inc....
Read More
BioCentury | Aug 12, 2013
Financial News

SetPoint Medical completes venture financing

SetPoint Medical Inc. , Valencia, Calif. Business: Inflammation Date completed: 8/8/13 Type: Venture financing Raised: $27 million Investors: Covidien Ventures; Action Potential Venture Capital; Boston Scientific Corp ; Morgenthaler Ventures; Foundation Medical Partners; Topspin Partners WIR...
Read More
BioCentury | Aug 12, 2013
Financial News

GlaxoSmithKline financial update

...and metabolic disorders like Type II diabetes. The strategic fund announced its first investment in SetPoint Medical Inc....
Read More
BioCentury | Aug 9, 2013
Financial News

SetPoint Medical raises $27M in series C

...Medical device company SetPoint Medical Inc. (Valencia, Calif.) raised $27 million in a series C round from all...
Read More
BioCentury | Aug 9, 2013
Financial News

GSK launches $50M bioelectronics fund

...and metabolic disorders like Type II diabetes. The strategic fund announced its first investment in SetPoint Medical Inc....
Read More
Items per page:
1 - 9 of 9
BioCentury | Oct 8, 2019
Emerging Company Profile

Flagship unveils Cygnal, a nervy take on cancer, inflammation

...seven bioelectronics companies via its $50 million Action Potential Venture Capital fund. Among these is SetPoint Medical Inc....
Read More
BioCentury | Jun 21, 2017
Company News

Management tracks

...Öhd to CMO, a newly created position, from director of clinical R&D. Inflammatory disease company SetPoint Medical Inc....
Read More
BioCentury | Aug 8, 2016
Product Development

Galvanizing bioelectronics

...a winner." Meanwhile, GSK's Action Potential Venture Capital fund has funded five bioelectronics companies, including SetPoint Medical Inc....
...NYSE:GSK), London, U.K. NeuSpera Medical Inc., San Jose, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland SetPoint Medical Inc....
Read More
BioCentury | Jan 5, 2015
Clinical News

Cyberonics Vagus Nerve Stimulation System: Clinical trial started

...an open-label, European trial to evaluate Cyberonics Vagus Nerve Stimulation System in about 15 patients. SetPoint Medical Inc....
Read More
BioCentury | Aug 19, 2013
Finance

Electric with potential

...made its maiden investment this month by participating in a $27 million private round in SetPoint Medical Inc....
Read More
BioCentury | Aug 12, 2013
Financial News

SetPoint Medical completes venture financing

SetPoint Medical Inc. , Valencia, Calif. Business: Inflammation Date completed: 8/8/13 Type: Venture financing Raised: $27 million Investors: Covidien Ventures; Action Potential Venture Capital; Boston Scientific Corp ; Morgenthaler Ventures; Foundation Medical Partners; Topspin Partners WIR...
Read More
BioCentury | Aug 12, 2013
Financial News

GlaxoSmithKline financial update

...and metabolic disorders like Type II diabetes. The strategic fund announced its first investment in SetPoint Medical Inc....
Read More
BioCentury | Aug 9, 2013
Financial News

SetPoint Medical raises $27M in series C

...Medical device company SetPoint Medical Inc. (Valencia, Calif.) raised $27 million in a series C round from all...
Read More
BioCentury | Aug 9, 2013
Financial News

GSK launches $50M bioelectronics fund

...and metabolic disorders like Type II diabetes. The strategic fund announced its first investment in SetPoint Medical Inc....
Read More
Items per page:
1 - 9 of 9